ANALYSIS OF THE TANDEM DUPLICATOR PHENOTYPE AS A NEW DRIVER AND BIOMARKER OF BRCA1-LINKED TO OVARIAN CANCER

$610,438FY2017Department of the ArmyDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators